Quelicin 01
Chemical structure of Quelicin 20 mg/mL showing its molecular components including quaternary ammonium groups and associated chloride ions.*
Quelicin Injection, Solution
Product Images NDC 0409-6629
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quelicin (NDC 0409-6629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Quelicin 02
Quelicin 03
Quelicin Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL) multi-dose vial label. The label includes warnings about its paralyzing effect and need for artificial respiration facilities. Contains preservatives methylparaben and propylparaben. Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.*
Quelicin 04
Packaging label for Quelicin 20 mg/mL (200 mg/10 mL) Succinylcholine Chloride Injection, USP. The label indicates a 10 mL multiple-dose vial, contains warning text about its paralyzing agent properties, and storage instructions to refrigerate between 2° to 8°C (36° to 46°F). The product is labeled Rx only and manufactured by Hospira, Inc.*
Quelicin 05
Label for Quelicin (succinylcholine chloride) injection, USP, 100 mg/mL in a 10 mL single-dose vial. The label includes warnings indicating it is a paralyzing agent requiring dilution and intravenous use only. Manufactured by Hospira, Inc., with storage recommended at 2° to 8°C.*
Quelicin 06
Label for Quelicin 20 mg/mL (Succinylcholine Chloride Injection, USP) in a 10 mL single-dose fliptop vial. The label includes dosage strength as 100 mg/mL equivalent, warnings about paralysis, storage instructions (store refrigerated at 2° to 8°C), and the Hospira, Inc. manufacturer information. It notes the vial contains 25 Units and must be diluted for intravenous use only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
